M&B Sciences

What M&B Sciences does

M&B Sciences, Inc. is a California-based, African American, Woman-Owned clinical research technology firm founded in 2021 and headquartered in San Diego. The company provides patient recruitment and retention services to pharmaceutical, biotech, and medical device sponsors across Phase I-IV trials, alongside HCAHPS and CAHPS for MIPS survey administration for healthcare providers, ACOs, and hospital systems. Its core technology stack consists of the NeighborhoodTrials.com web and mobile platform, the proprietary M&B Data Engine (which combines spatial epidemiology, census tract data, EMR, and discharge data to identify high-potential recruitment geographies), M&B Care patient support technology backed by a 50-person call center, an in-house e-Consent platform, and the Clara Platform acquired from Clara Health in March 2022 for decentralized and hybrid trial capabilities.

The company monetizes primarily through custom-quoted, project-based, multi-year enterprise engagements sold via direct field sales to sponsors, study sites, and CROs, supplemented by a free self-serve patient portal distributed through the Apple App Store and Google Play Store. Marketing reaches sponsors and patients through thought-leadership content, industry conferences (e.g., SCRS Diversity Site Solutions Summit, CMSC Annual Meeting), targeted digital advertising, and a community/patient advocacy partner network. The firm is founder-controlled by Dr. Eddilisa Martin (Founder, Owner, CEO & Pharmacist), with no disclosed institutional funding, a small core technology team, and a larger dedicated call center for patient concierge and survey administration operations.

Name

M&B Sciences

Legal name

M&B Sciences, Inc

Website

https://mbsciences.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

M&B Sciences is a San Diego-based clinical research technology firm that uses spatial epidemiology and AI-driven patient matching (via its NeighborhoodTrials.com platform and Clara Platform) to recruit and retain diverse patient populations for pharma, biotech, and CRO-sponsored clinical trials.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Recruitment Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Patient Recruitment & Retention (HLAGACAD)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial recruitment
• Patient recruitment services
• Decentralized clinical trials
• Patient experience surveys
• Spatial epidemiology analytics

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Patient Recruitment and Retention Services: M&B Sciences provides full-service patient recruitment and retention to pharmaceutical, biotech, and medical device companies across Phase I-IV and device trials. Services include naive investigator recruitment and training, digital marketing, multi-channel patient outreach, patient travel coordination, and 24/7 concierge support.
2. HCAHPS and CAHPS for MIPS Survey Administration: End-to-end survey administration for healthcare organizations, including vendor authorization support, mail and CATI administration, patient engagement call center operations, data collection, quality assurance, and CMS reporting support.
3. Clinical Trial Operations and Site Management: Includes site operations, on-site/remote/centralized monitoring, quality assurance, inspection readiness support, and project management of clinical development programs.
4. Customizable Survey and Data Collection Solutions: Advanced quality assurance tools, instrument development and testing, OMB/IRB clearance package preparation, cognitive monitoring, structured interviews, focus groups, and nationwide field interviewing services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

M&B Sciences provides full-service patient recruitment and retention for clinical trials conducted by pharmaceutical, biotech, and medical device sponsors, leveraging proprietary spatial epidemiology technology, neighborhood-level demographic data, and AI-driven patient matching through the NeighborhoodTrials.com platform. The company also operates a 50-person patient concierge call center and provides end-to-end HCAHPS and CAHPS for MIPS survey administration services to healthcare providers, groups, ACOs, and hospital systems required to report patient experience to CMS.

Product overview

M&B Sciences offers a unified platform-plus-services model combining proprietary technology tools with comprehensive clinical trial services. The core offering consists of the M&B Sciences Platform and NeighborhoodTrials.com (an A.I.-driven web and mobile application) supplemented by the acquired Clara Platform. Services include patient recruitment and retention, HCAHPS/CAHPS survey administration, clinical operations, project management, data analytics, and multi-channel outreach support. The company also provides in-house e-consent, demographic diversity tools, digital marketing, and 24/7 patient support through M&B Care. Together, these products enable sponsors, study sites, and CROs to accelerate recruitment with 2-8x faster pace while increasing demographic diversity in clinical trials.

Differentiator

Problem solved

Functional benefit

Brands

• NeighborhoodTrials.com: Patient recruitment web and mobile app platform connecting patients with clinical trials
• M&B Concierge Service
• M&B Care

Products and services

• M&B Sciences Platform An extensive and extensible proprietary technology platform enabling scalable patient recruitment and retention for clinical trials. Supports creation of neighborhood-specific study pages, digital prescreening tools, secure data capture, and multi-channel patient outreach via web, email, mobile, SMS, IVR, and face-to-face channels for biotech, pharmaceutical, and CRO clients.
• NeighborhoodTrials.com A customized, interactive, AI data-driven web and mobile application (available in the Apple App Store and Google Play Store) that connects patients, community-based organizations, sponsors, and investigators to clinical trial opportunities with a focus on underrepresented populations. Features spatial epidemiology-based patient matching and neighborhood-specific trial discovery.
• Clara Platform Innovative patient recruitment and retention technology platform acquired from Clara Health in March 2022. Provides protocol design, site selection, and retention tools with patient-centric technology for decentralized and hybrid clinical trials; being integrated with NeighborhoodTrials.com.
• M&B Care Patient support technology and 24/7 concierge service providing live chat, phone, SMS, and email support for patient applicants, integrated with a 50-person call center that coordinates travel booking, meal services, and patient stipend issuing for clinical trial participants.
• HCAHPS and CAHPS for MIPS Survey Administration End-to-end HCAHPS and CAHPS for MIPS survey administration for healthcare organizations, including vendor authorization support, mail and CATI administration aligned with CMS requirements, patient engagement call center operations, data collection, quality assurance, and CMS reporting support.

Quantifiable outcome

• 2-8x faster patient recruitment pace compared to industry benchmarks
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Clara HealthcoreStrategic or Co-development Partner · 1 March 2022M&B Sciences acquired Clara Health on March 1, 2022. Clara Health, founded in 2015 by Evan Ehrenberg and Sol Chen, brought its innovative Clara Platform — a patient recruitment and retention technology — to M&B Sciences. The acquisition expanded M&B's ability to offer decentralized and hybrid trial technology tools. The Clara Platform is being integrated with NeighborhoodTrials.com to combine the best of both platforms.
• PatientsLikeMeminorStrategic or Co-development PartnerPatientsLikeMe partnered with M&B Sciences to conduct research studies on transplant care partner experiences (with Takeda) and major depressive disorder (with Takeda Pharmaceuticals). M&B Sciences hosts and promotes these studies on its platform, recruiting participants through the blog and patient networks.
• Takeda PharmaceuticalsminorStrategic or Co-development PartnerTakeda partnered with PatientsLikeMe and M&B Sciences to conduct research studies on transplant care partners and major depressive disorder patients, gathering real-world data on patient medication experiences, treatment patterns, and quality of life outcomes.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Trial Library: AI-driven clinical trial patient recruitment platform focused on community-based provider networks and underrepresented populations — niche overlap with M&B's diversity-and-community positioning.

Direct peers

• THREAD: Decentralized clinical trial and patient recruitment platform that acquired Antidote — directly overlapping with M&B's combined NeighborhoodTrials + Clara Platform offering.
• BBK Worldwide: Long-established patient recruitment and engagement services firm for pharma and biotech — comparable services-led recruitment model targeting the same sponsor customers.
• Deep 6 AI: AI-native patient recruitment platform that mines EMR and structured clinical data to match patients to trials — directly comparable to M&B's EMR- and census-tract-driven matching engine.
• Curebase: Decentralized and hybrid clinical trial operator offering patient recruitment and site-less trial execution — directly competes in the same decentralized trial technology category M&B entered via Clara Health.
• Antidote (now part of THREAD): Patient recruitment and clinical trial matching platform focused on connecting patients to relevant trials — same core use case as M&B's NeighborhoodTrials.com, with comparable AI-driven matching and partner-sponsor model.
• Mendel (Mendel.ai): AI platform for structuring clinical data and accelerating patient recruitment and cohort identification for pharma and CROs — overlapping technology stack and sponsor customer base.

Broad incumbents

• Science 37: Pioneer in decentralized clinical trials offering end-to-end recruitment, telemedicine, and home-based trial operations — larger, well-funded incumbent in adjacent decentralized trial space.
• IQVIA: Largest global CRO with embedded patient recruitment, real-world data, and site networks — sets the competitive ceiling that specialty recruitment vendors like M&B must differentiate against.
• Press Ganey (HCAHPS/CAHPS survey administration): Dominant HCAHPS/CAHPS for MIPS survey administration vendor for hospitals and provider groups — directly comparable to M&B's HCAHPS/CAHPS for MIPS service line targeting CMS-reporting healthcare organizations.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/drlisamartin
• LinkedInlinkedin.com/company/2m-clinical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M&B Sciences